Target intelligence / Profile preview

Cytoskeletal and Junctional Proteins

Molecular classification
Structural protein, Cytoskeletal protein, Cell adhesion molecule
01

Overview

Cytoskeletal and Junctional Proteins encompass a diverse group of structural and regulatory proteins that maintain cellular architecture and facilitate communication between cells and the extracellular matrix. The cytoskeleton is composed of three primary filament systems—microfilaments (actin), intermediate filaments (e.g., keratins, lamins), and microtubules (tubulin)—which are essential for cell division, intracellular transport, and motility (UniProt). Junctional proteins, including cadherins, claudins, and integrins, form specialized structures like tight junctions and desmosomes that ensure tissue integrity and regulate paracellular transport (StatPearls). In disease states, particularly oncology, the remodeling of these proteins is a key driver of the epithelial-mesenchymal transition (EMT), enabling tumor invasion and metastasis (PubMed). Pharmacological intervention typically targets specific subunits, such as microtubule-stabilizing agents (taxanes) used in cancer or integrin antagonists used in autoimmune and inflammatory conditions (NIH). Due to the fundamental and ubiquitous nature of these proteins across all tissue types, therapeutic development faces significant challenges in achieving tissue-specific delivery and minimizing systemic side effects.

Other names
Cytoskeleton proteinsCell junction proteinsStructural proteinsCell adhesion molecules
02

Mechanism of action

Modulation of protein polymerization (e.g., microtubule stabilization or destabilization) and inhibition of cell-cell or cell-matrix adhesion through competitive binding to junctional receptors.

03

Biological functions

Cell structure maintenanceCell motilityCell-cell adhesionIntracellular transportSignal transduction
04

Disease associations

CancerMuscular dystrophyCardiovascular diseaseInflammatory diseasesNeurological disorders
05

Safety considerations

Systemic toxicityPeripheral neuropathyImpaired wound healingCardiotoxicityImmunosuppression
06

Interacting drugs

Paclitaxel

5 more in the full profile.

07

Biomarkers

E-cadherinVimentinCardiac TroponinDesminCytokeratin

Beyond the preview

Go deeper on Cytoskeletal and Junctional Proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytoskeletal and Junctional Proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call